PHARMACOKINETIC (PK) PROFILE OF LIPOSOMAL AMIKACIN FOR INHALATION (LAI) IN PATIENTS WITH CYSTIC FIBROSIS (CF) AND CHRONIC PSEUDOMONAS AERUGINOSA INFECTION

被引：0

作者：

Clancy, J. P. ^{[1
]}

Konstan, M. ^{[1
]}

Fajac, I ^{[1
]}

Pressler, T. ^{[1
]}

Sands, D. ^{[1
]}

Minic, P. ^{[1
]}

Cipolli, M. ^{[1
]}

Bilton, D. ^{[2
]}

Eagle, G. ^{[3
]}

McGinnis, J. ^{[3
]}

Monroe, R. ^{[3
]}

Rubino, C. ^{[4
]}

机构：

[1] CF LAI Study Grp, Bridgewater, NJ USA

[2] Royal Brompton Hosp, London SW3 6LY, England

[3] Insmed Inc, Bridgewater, NJ USA

[4] Inst Clin Pharmacodynam, Latham, NY USA

来源：

PEDIATRIC PULMONOLOGY | 2015年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

444

引用

页码：358 / 359

页数：2

共 50 条

[21] Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
McKeage, Kate
DRUGS, 2013, 73 (16) : 1815 - 1827
[22] Defining chronic Pseudomonas aeruginosa infection in cystic fibrosis
Waters, Valerie
Grimwood, Keith
JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (03) : 292 - 293
[23] Prevention of chronic infection with Pseudomonas aeruginosa infection in cystic fibrosis
Zemanick, Edith T.
Bell, Scott C.
CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (06) : 636 - 645
[24] Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
Srilekha Panguluri
Praveen Gunda
Laurie Debonnett
Kamal Hamed
Clinical Drug Investigation, 2017, 37 : 795 - 805
[25] Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
Kate McKeage
Drugs, 2013, 73 : 1815 - 1827
[26] Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
Panguluri, Srilekha
Gunda, Praveen
Debonnett, Laurie
Hamed, Kamal
CLINICAL DRUG INVESTIGATION, 2017, 37 (08) : 795 - 805
[27] Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis
Assael, Baroukh Maurice
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (11) : 967 - 973
[28] Host adaptation of Pseudomonas aeruginosa during chronic infection of the cystic fibrosis (CF) lung.
Hogardt, M.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 297 : 29 - 30
[29] The Costs of Treatment of Early and Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients
Braccini, G.
Festini, F.
Boni, V.
Neri, A. S.
Galici, V.
Campana, S.
Zavataro, L.
Trevisan, F.
Braggion, C.
Taccetti, G.
JOURNAL OF CHEMOTHERAPY, 2009, 21 (02) : 188 - 192
[30] Tobramycin Inhalation Powder Is Effective and Safe in the Treatment of Chronic Pulmonary Pseudomonas aeruginosa (Pa) Infection in Patients with Cystic Fibrosis
Konstan, M. W.
Geller, D. E.
Brockhaus, F.
Zhang, J.
Angyalosi, G.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179

← 1 2 3 4 5 →